Chief Scientific Officer at ReVision Therapeutics, Inc. - N/A, N/A, US
Chief Business Officer/Advisor
Contact Kathryn Gregory
ReVision Therapeutics is an ophthalmic biopharmaceutical company developing a novel, small-molecule drug for the treatment and prevention of dry age-related macular degeneration.